skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8850

Editorial: Nanomedicine: real commercial potential or just hype? ||FREE PAPER||

(2693) Views  (417) Full article downloads

Authors: Thomas J Webster

Published Date May 2006 Volume 2006:1(4) Pages 373 - 374
DOI: http://dx.doi.org/10.2147/IJN.S

Thomas J Webster

Divisions of Engineering and Orthopedics, Brown University, Providence, RI, USA

What is the real commercial potential for nanotechnology and, in particular, nanomedicine? Depends on your definition. For example, if you think nanomedicine refers to Michael Crichton’s self-replicating nanorobots traversing the body and healing disease (as in his 2002 novel Prey), I bet you will be waiting a long time (if ever) to see commercial fruition. On the other hand, if you envision nanomedicine as listening to meditation music from your iPod nano (and, thus, healing your soul), then you are in luck as you are already experiencing commercial benefits of nanomedicine. If only you had bought the stock.








Readers of this article also read:

Drug delivery and nanoparticles: Applications and hazards
Evidence-based decision-making within the context of globalization: A “Why–What–How” for leaders and managers of health care organizations
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
"Globalized public health.” A transdisciplinary comprehensive framework for analyzing contemporary globalization’s influences on the field of public health
Nanomedicine: promises and challenges for the future of public health
Amino acid management of Parkinson’s disease: a case study
Comparison of two treatments for coxarthrosis: local hyperthermia versus radio electric asymmetrical brain stimulation
Elucidation mechanism of different biological responses to multi-walled carbon nanotubes using four cell lines